Tirzepatide for Metabolic Dysfunction–Associated Steatohepatitis with Liver Fibrosis

Rohit Loomba, M.D., Mark L. Hartman, M.D., Eric J. Lawitz, M.D., et al, for the SYNERGY-NASH Investigators* Published June 8, 2024 N Engl J Med 2024;391:299-310 DOI: 10.1056/NEJMoa2401943 Πατώντας ΕΔΩ μπορείτε να δείτε την περίληψη του άρθρου

Λεπτομέρειες

Predictors of hepatic flares after nucleos(t)ide analogue cessation – Results of a global cohort study (RETRACT-B study)

Dongelmans EJ, Hirode G, Hansen BE, Chen CH, Su TH, Seto WK, Furquim d’Almeida A, van Hees S, Papatheodoridi M, Lens S, Wong GLH, Brakenhoff SM, Chien RN, Feld JJ, Chan HLY, Forns X, Papatheodoridis GV, Vanwolleghem T, Yuen MF, Hsu YC, Kao JH, Cornberg M, Sonneveld MJ, Jeng WJ, Janssen HLA, on behalf of…

Λεπτομέρειες

We have reached single-visit testing, diagnosis, and treatment for hepatitis C infection, now what?

Grebely J, Matthews S, Causer LM, Feld JJ, Cunningham P, Dore GJ, Applegate TL. We have reached single-visit testing, diagnosis, and treatment for hepatitis C infection, now what? Expert Rev Mol Diagn. 2024 Mar;24(3):177-191. Πατώντας ΕΔΩ μπορείτε να δείτε την περίληψη του άρθρου

Λεπτομέρειες

Effectiveness and safety of glecaprevir/pibrentasvir for 8 weeks in the treatment of patients with acute hepatitis C: A single-arm retrospective study

Pol S, Thompson A, Collins M, Venier E, Cotte L, Laguno Centeno M, et al. Effectiveness and safety of glecaprevir/pibrentasvir for 8 weeks in the treatment of patients with acute hepatitis C: A single-arm retrospective study. Hepatology, May 20, 2024. | DOI: 10.1097/HEP.0000000000000923 Πατώντας ΕΔΩ μπορείτε να δείτε την περίληψη του άρθρου

Λεπτομέρειες

Severe acute liver disease in adults: Contemporary role of histopathology

Clouston A D, Gouw A S H, Tiniakos D, Bedossa P, Brunt E M, Callea F, Dienes H-P, Goodman Z D,Hubscher S G, Kakar S, Kleiner D E, Lackner C, Park Y N, Roberts E A, Schirmacher P, Terracciano L,Torbenson M, Wanless I R, Zen Y & Burt A D(2024) Histopathology. https://doi.org/10.1111/his.15212 ΕΔΩ μπορείτε να…

Λεπτομέρειες

Limited Sustained Remission After Nucleos(t)ide Analog Withdrawal: Results From a Large, Global, Multiethnic Cohort of Patients With Chronic Hepatitis B (RETRACT-B Study)

Grishma H, Bettina H, Chien-Hung C et al, on behalf of the RETRACT-B study group. Am J Gastroenterol, 2024 DOI: 10.14309/ajg.0000000000002759 Πατώντας ΕΔΩ μπορείτε να δείτε την περίληψη του άρθρου

Λεπτομέρειες

Carvedilol Plus NUC for Patients With HBV-Compensated Cirrhosis Under Virological Suppression: A Randomized Open-Label Trial

Wang B, Zhou J, Wu X, Sun Y, Li L, Li P, et al. Carvedilol Plus NUC for Patients With HBV-Compensated Cirrhosis Under Virological Suppression: A Randomized Open-Label Trial. Am J Gastroenterol. 2024 Apr 1;119(4):700-711. doi: 10.14309/ajg.0000000000002569. Epub 2023 Nov 6. PMID: 37929952 Πατώντας ΕΔΩ μπορείτε να δείτε την περίληψη του άρθρου

Λεπτομέρειες